BluePoint Laboratories is recalling 97,975 vials of Cyanocobalamin Injection, USP (Vitamin B12), 1000 mcg per mL. This prescription medication, which is used to treat vitamin deficiencies, was found to be subpotent, meaning it contains less than the required amount of the active ingredient. No incidents or injuries have been reported to date. This recall affects vials distributed in Alabama.
Patients using the subpotent injection may not receive the full intended dose of Vitamin B12, which can result in ineffective treatment of vitamin deficiencies or related medical conditions.
You have 2 options:
Manufactured by Eugia Pharma Specialties Limited for BluePoint Laboratories.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.